Document ID: chunk:federal_register_of_legislation:C2025C00090:front:0:p5
Version: federal_register_of_legislation:C2025C00090
Segment Type: other
Provision Reference: 
Character Range: 11586–14892

the price disclosure requirements apply
Subdivision D—Consequences for failing to comply with the price disclosure requirements
99ADF Offence for failing to comply with the price disclosure requirements
99ADG Other consequences for failing to comply with the price disclosure requirements
Subdivision E—Price reduction
99ADH Price reduction based on information provided under the price disclosure requirements
99ADHA Price reduction for brands listing after end of data collection period
99ADHB Flow on price reductions for brands of combination items
Division 3BA—Floor price of a brand of a pharmaceutical item
99ADHC Floor price of a brand of a pharmaceutical item
99ADHD Meaning of previous data collection period
Division 3C—Guarantee of supply
Subdivision A—Preliminary
99AE What this Division is about
99AEA Definitions
Subdivision B—Guarantee of supply
99AEB Guarantee of supply
Subdivision C—Brands that are guaranteed brands
99AEC Guaranteed brand: new brand
99AED Guaranteed brand: first brand to offer a lower price
Subdivision D—Meaning of fails to supply and unable to supply
99AEE Meaning of fails to supply
99AEF Meaning of unable to supply
Subdivision E—Requirement to notify Minister of failure or inability to supply etc.
99AEG Requirement to notify Minister of failure to supply etc.
Subdivision F—Consequences for guaranteed brands of failure or inability to supply
99AEH Minister's powers if responsible person fails to supply, or is unable to supply, guaranteed brand
Subdivision G—Consequences for other brands
99AEI Minister may increase approved ex‑manufacturer price if guaranteed brand delisted
99AEJ Minister may determine drug is on F1 if guaranteed brand delisted
99AEK Minister may revoke or vary formulary determination if guaranteed brand delisted
Division 3CAA—Minimum stockholding requirement
99AEKA Brands subject to the minimum stockholding requirement
99AEKB Minimum stockholding requirement
99AEKC Applicable quantity of a brand of a pharmaceutical item
99AEKD Minister to be notified of breach of minimum stockholding requirements
99AEKE Minister's power if responsible person breaches minimum stockholding requirement
99AEKF Stockholding disclosure requirements
Division 3CA—Discounts and incentives
99AEL Minister's powers if responsible person offers discounts or incentives for certain brands of pharmaceutical items
Division 4—Provisions relating to members of the Pharmaceutical Benefits Remuneration Tribunal
99A Terms and conditions of appointment
99B Remuneration and allowances
99C Resignation and removal from office
99D Acting Chairperson
99E Acting additional member
Division 4A—Indexation etc.
Subdivision A—Preliminary
99F Definitions
Subdivision B—Indexation
99G Indexation
Subdivision C—Reduction of allowable discounts
99GA Definitions
99GB Supplies to which this Subdivision applies
99GC Reduction of allowable discount relating to the general patient charge
99GD Reduction of allowable discounts relating to the general patient reduced charge and concessional beneficiary charge
99GE Effect of reduction in allowable discount
Division 4B—Australian Community Pharmacy Authority
99H Interpretation
99J Establishment of Authority
99K Functions
99L Determination of rules by Minister
99M Powers
99N Membership
99P Terms and conditions not provided